Skip to main content
logo
Guizhou Sanli Pharmaceutical Co.,Ltd (SHA:603439)
China flag China · Delayed Price · Currency is CNY
11.55
-0.37 (-3.10%)
Sep 10, 2026, 1:15 PM CST

SHA:603439 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-1.3546.25274.03292.7201.28152.28
Depreciation & Amortization
70.0274.0275.7236.916.1911.17
Other Amortization
1.010.90.290.691.660.04
Loss (Gain) From Sale of Assets
-0.10.120.17-0.590.090.15
Asset Writedown & Restructuring Costs
123.11122.010.570.050.180.01
Loss (Gain) From Sale of Investments
2.252.62-1.96-55.16-10.96-17.87
Provision & Write-off of Bad Debts
-5.58-5.589.93.3510.30.99
Other Operating Activities
33.0434.4631.5110.89-3.954.79
Change in Accounts Receivable
228.17196.23-295.56-124.07-79.55-83.04
Change in Inventory
132.6892.68-147.99-7.06-9.45-41.13
Change in Accounts Payable
-331.62-408.69167.69119.02161.24127.24
Change in Other Net Operating Assets
12.9913.730.154.146.30.76
Operating Cash Flow
258.6164.58107.07276.7293.29155.04
Operating Cash Flow Growth
154.76%53.71%-61.30%-5.66%89.17%145.13%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-29.05-25.84-45.2-108.73-119.91-26.08
Sale of Property, Plant & Equipment
0.450.640.552.050.180.05
Cash Acquisitions
----543.04-160.04-
Divestitures
-0.09-0.09--0.010.65-
Investment in Securities
-12.97-203.8-59.9634.53880.7
Other Investing Activities
15.010.661.611.451.92-34.08
Investing Cash Flow
-26.67-228.44-103-613.78-266.5620.59

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
-----200
Long-Term Debt Issued
-570.54351.22504205-
Total Debt Issued
522.37570.54351.22504205200
Short-Term Debt Repaid
------200
Long-Term Debt Repaid
--422.94-309.7-205.45-200-
Lease Payments
-4.03-4.03-9.85-0.45--
Total Debt Repaid
-649.63-422.94-309.7-205.45-200-200
Net Debt Issued (Repaid)
-127.25147.641.52298.555-
Issuance of Common Stock
--39.23--26.55
Repurchase of Common Stock
-7.73-7.73-100.41-30--
Common Dividends Paid
-46.31-161.44-104.04-50.92-8.92-110.21
Dividends Paid
-46.31-161.44-104.04-50.92-8.92-110.21
Other Financing Activities
-25.16-23.121203.82.2
Financing Cash Flow
-206.45-21.57-100.6337.63-0.12-81.46

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
25.49-85.43-96.530.5526.694.17

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
229.55138.7461.87167.97173.38128.96
Free Cash Flow Growth
262.39%124.23%-63.16%-3.12%34.45%1017.56%
Free Cash Flow Margin
14.71%8.15%2.89%10.27%14.43%13.73%
Free Cash Flow Per Share
0.550.330.150.410.420.31
Levered Free Cash Flow
172.22-57.5297.61-36.78127.6854.78
Unlevered Free Cash Flow
179.14-50.6106.74-34.2130.9659.99
Free Cash Flow After Leases
225.52134.752.02167.52173.38128.96

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Income Tax Paid
187.02191.18210.8175.31116.04100.28
Change in Working Capital
36.22-110.22-283.17-12.1378.493.47